13.02MMarket Cap-0.34P/E (TTM)
10.9600High8.0200Low230.87KVolume8.4900Open8.2600Pre Close2.26MTurnover23.92%Turnover RatioLossP/E (Static)1.30MShares30.900052wk High1.88P/B9.63MFloat Cap2.118052wk Low--Dividend TTM965.13KShs Float86364.0000Historical High--Div YieldTTM35.59%Amplitude2.1150Historical Low9.7820Avg Price1Lot Size
Ensysce Biosciences Stock Forum
These are also in the same boat:
$Ensysce Biosciences (ENSC.US)$
$Reborn Coffee (REBN.US)$
▪️This is NOT a BUY signal/advice.
▪️Trade the chart/indicators/order book.
▪️No set-up, No trade.
▪️Your trade, your SOLE accountability.
$Achilles Therapeutics (ACHL.US)$
$reAlpha Tech (AIRE.US)$
$Color Star Technology (ADD.US)$
$Adagio Medical (ADGM.US)$
$AGM Group (AGMH.US)$
$Airship AI (AISP.US)$
$Xiao-I (AIXI.US)$
...
we are going up up and up
SIRI and OXY are attractively valued for minimal returns.
$Sirius XM (SIRI.US)$ holds the most long term value as it has the best chance of obtaining higher percentage gains.
You should adjust your investment strategy as often as possible in order to achieve maximum gains.
These are short term investments for maximum gains:
$Reborn Coffee (REBN.US)$ Has resistance at 2.04 and th...
📊⚡️📊
Dec. 23, 2024 8:12 AM
Ensysce Biosciences Regains Full Compliance with Nasdaq
Monday, 23rd December at 8:00 am
SAN DIEGO, CALIFORNIA / ACCESSWIRE / December 23, 2024 / Ensysce Biosciences, Inc. (NASDAQ: ENSC) ("Ensysce" or "Company"), a clinical-stage pharmaceutical company developing innovative solutions for severe pain relief while reducing the potential for opioid abuse and overdose, today announced that on December 20, 2024, it received notice from The Nasdaq Stock Market LLC ("...
No comment yet